Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs



The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *